North America Lung Cancer Diagnostics Market to 2032

Overview

The North America Lung Cancer Diagnostics Market is expected to reach a 7,282.93 USD Billion by 2032 and is projected to grow at a CAGR of 21.11% from 2025 to 2032.

Revenue, 2024 (USD Billion)

2,389.16

Forecast, 2032 (USD Billion)

7,282.93

CAGR, 2024 - 2032

21.11%

Report Coverage

North America

North America Lung Cancer Diagnostics Market 2018-2032 USD Billion

North America Lung Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 2,389.16 USD Billion
Projected Market Size (2032): 7,282.93 USD Billion
CAGR (2025-2032): 21.11%

Key Findings of North America Lung Cancer Diagnostics Market

The North America Lung Cancer Diagnostics Market was valued at 2,389.16 USD Billion in 2024.
The North America Lung Cancer Diagnostics Market is likely to grow at a CAGR of 21.11% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 1,830.75 USD Billion
The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 23.82% during the forecast period from 2024 to 2032.

North America Lung Cancer Diagnostics Market Scope

North America Lung Cancer Diagnostics Market Segmentation & Scope

Product

Consumables & Accessories
Instruments

End User

Others
Cancer Research Institutes
Diagnostic Imaging Centers
Independent Diagnostic Laboratories
Associated Labs
Hospital

Cancer

Small Cell Lung Cancer
Non-Small Cell Lung Cancer

Test

Others
Blood Test
Biopsy
Biomarkers Test
Imaging Test

Distribution Channel

Direct Tender
Retail Sales

North America Lung Cancer Diagnostics Market Data Coverage Insights

Study Period	2024-2032
Base Year	2021
Unit	Revenue in USD Billion
Market Value in 2024	2,389.16 USD Billion
Market Value in 2032	7,282.93 USD Billion
CAGR (2025-2032)	21.11%
Historic Data	2016-2023
Market Segments Covered	Product,End User,Cancer,Test,Distribution Channel

Regional Insights:

Leading Market (2024-2032): North America, leading in terms of revenue 2,389.16 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,915.06 USD Billion in 2024.

Segments and Scope

North America Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in North America Lung Cancer Diagnostics Market to 2032 with a revenue of 1,511.35 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in North America Lung Cancer Diagnostics Market to 2032 with a Growth rate of 22.08 % in forecast period 2025-2032.
North America Lung Cancer Diagnostics Market to 2032, By End User
- Hospital is the largest segment in North America Lung Cancer Diagnostics Market to 2032 with a revenue of 613.53 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in North America Lung Cancer Diagnostics Market to 2032 with a Growth rate of 23.82 % in forecast period 2025-2032.
North America Lung Cancer Diagnostics Market to 2032, By Cancer
- Non-Small Cell Lung Cancer is the largest segment in North America Lung Cancer Diagnostics Market to 2032 with a revenue of 1,830.75 USD Billion in the year 2024.
- Small Cell Lung Cancer is the Fastest growing segment in North America Lung Cancer Diagnostics Market to 2032 with a Growth rate of 11.97 % in forecast period 2025-2032.
North America Lung Cancer Diagnostics Market to 2032, By Test
- Imaging Test is the largest segment in North America Lung Cancer Diagnostics Market to 2032 with a revenue of 1,162.77 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in North America Lung Cancer Diagnostics Market to 2032 with a Growth rate of 22.31 % in forecast period 2025-2032.
North America Lung Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Lung Cancer Diagnostics Market to 2032 with a revenue of 1,322.10 USD Billion in the year 2024.
- Retail Sales is the Fastest growing segment in North America Lung Cancer Diagnostics Market to 2032 with a Growth rate of 8.28 % in forecast period 2025-2032.

North America Lung Cancer Diagnostics Market Company Share Analysis

Company Name
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Bio-Rad Laboratories, Inc.
Abbott
Guardant Health

North America Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

North America Lung Cancer Diagnostics Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market

Middle East & Africa Hospital Furniture Market

North America Hospital Furniture Market

Europe Hospital Furniture Market

Asia-Pacific Hospital Furniture Market

Argentina Hospital Furniture Market

Australia Hospital Furniture Market

Belgium Hospital Furniture Market

Brazil Hospital Furniture Market

Canada Hospital Furniture Market

Frequently Asked Questions

What are the primary segments covered in the North America Lung Cancer Diagnostics Market?

The North America Lung Cancer Diagnostics Market is segmented based on Segmentation Product,End User,Cancer,Test,Distribution Channel.

What is the current market size of the North America Lung Cancer Diagnostics Market?

North America Lung Cancer Diagnostics Market was valued at USD 2,389.16(Revenue in USD Billion) in 2021.

What is the expected growth rate of the North America Lung Cancer Diagnostics Market?

North America Lung Cancer Diagnostics Market is projected to grow at a CAGR of 21.11% during the forecast period of 2024 to 2032.

Which is the dominating segment in the North America Lung Cancer Diagnostics Market?

The Non-Small Cell Lung Cancer segment is expected to dominate the North America Lung Cancer Diagnostics Market, holding a largest market share of 1,830.75 USD Billion in 2024